Table 1.

Clinical characteristics of patients in the three cohorts included in the study.

	CCCC African American N=39	TCGA African American N=31	TCGA White N=96	p-value
Tumor stage:				0.513
Stage I	5 (15.6%)	5 (16.1%)	15 (16.3%)
Stage II	11 (34.4%)	6 (19.4%)	30 (32.6%)
Stage III	10 (31.2%)	10 (32.3%)	33 (35.9%)
Stage IV	6 (18.8%)	10 (32.3%)	14 (15.2%)
Age (years)	56.9 (11.2)	61.4 (12.2)	67.2 (11.9)	<0.001
Sex:				0.555
Female	15 (39.5%)	13 (41.9%)	47 (49.0%)
Male	23 (60.5%)	18 (58.1%)	49 (51.0%)
BMI:				0.521
Normal	14 (36.8%)	6 (23.1%)	26 (32.9%)
Underweight	1 (2.63%)	0 (0.00%)	0 (0.00%)
Overweight	14 (36.8%)	9 (34.6%)	27 (34.2%)
Obese	9 (23.7%)	11 (42.3%)	26 (32.9%)

BMI, body mass index